Minimal/Measurable Residual Disease Monitoring in <i>NPM1</i>-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives

Minimal/Measurable Residual Disease Monitoring in <i>NPM1</i>-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives

Acute myeloid leukemia (AML) with <i>NPM1</i> gene mutations is currently recognized as a distinct entity, due to its unique biological and clinical features. We summarize here the results of published studies investigating the clinical application of minimal/measurable residual disease...

Full description

Bibliographic Details
Main Authors: Fabio Forghieri, Patrizia Comoli, Roberto Marasca, Leonardo Potenza, Mario Luppi
Format: Article
Language:English
Published: MDPI AG 2018-11-01
Series:International Journal of Molecular Sciences
Subjects:
<i>NPM1</i>-mutated acute myeloid leukemia
molecular minimal/measurable residual disease monitoring
prognostic thresholds and timepoints
intensive chemotherapy
allogeneic hematopoietic stem cell transplantation
clinical outcome
Online Access:https://www.mdpi.com/1422-0067/19/11/3492

Internet

https://www.mdpi.com/1422-0067/19/11/3492

Similar Items